Markets Stocks Economy Crypto Earnings Banking Energy
Home› Markets› Feature
Markets · Exclusive

Asian ADRs edge higher as Concord Medical jumps, Jiayin slides

Asian ADRs edge higher as Concord Medical jumps, Jiayin slides
Markets · 2026
Photo · Eleanor Whitfield for Daily Digest Invest
By Eleanor Whitfield Markets Editor-in-Chief Nov 3, 2026 4 min read

US-listed shares of Asian companies edged higher Tuesday morning, with the S&P Asia 50 ADR Index rising 0.19% to 2,825.74. But the modest gain masked a market that was anything but uniform, as several constituents posted outsized moves in both directions.

Among the biggest winners was Concord Medical Services, a diagnostic imaging center operator, which jumped 9.5%. Semiconductor company Silicon Motion Technology rose 6.5%, while video game developer The9 gained 6.2%. In the crypto-mining space, Canaan added 6.4%, and India's HDFC Bank climbed 2.2% while Sea ticked up 1.3%.

On the losing side, Chinese fintech Jiayin fell 4.9%, and LexinFintech dropped 3%. Indonesia's Telekomunikasi Indonesia slid 3%, and India's Infosys declined 2%. Put simply, winners and losers largely canceled each other out in the index, even though individual stocks were swinging sharply.

What are ADRs and why do they matter?

American Depositary Receipts (ADRs) are US-traded certificates that represent shares in foreign companies. They allow everyday investors to buy and sell overseas firms on US exchanges without dealing with foreign currencies or cross-border brokerage accounts. The S&P Asia 50 ADR Index tracks 50 of the largest and most liquid Asian companies listed in the US, offering a snapshot of how Asian equities are performing during US trading hours.

For many investors, ADRs are a convenient way to gain exposure to fast-growing Asian markets, from Chinese tech giants to Indian banks and Southeast Asian e-commerce firms. But as Tuesday's action shows, the index can sometimes tell a different story than the individual stocks within it.

Why the index barely moved despite big swings

Index headlines can look like a clean read on "Asia sentiment," but they're really just weighted averages. When single-stock moves are this dispersed, big gains in a few constituents can offset sharp declines elsewhere, leaving an index that barely budges while portfolio-level risk is still high.

That dynamic is often stronger in ADRs because many of them trade with thinner liquidity during US hours, especially early in the session, which can exaggerate gaps and percentage swings. So a quiet index print can still coincide with a choppy day for anyone exposed to US-listed Asian single names.

For context, this kind of dispersion is not unusual. Asian tech stocks have been volatile recently as investors weigh earnings and valuations, and European ADRs have also shown similar patterns where sector moves offset each other.

What it means for investors

For everyday investors, the takeaway is that index moves can be misleading. A flat or slightly higher index doesn't mean all Asian ADRs are stable. If you hold individual ADRs, your experience could be very different from what the index suggests.

Tuesday's action highlights the importance of looking beyond the headline number. Concord Medical's 9.5% jump and Jiayin's 4.9% drop are significant moves that would matter to anyone holding those specific stocks. The index simply averages them out.

Investors should also be aware that ADRs can be more volatile than their underlying shares due to thinner trading volumes in the US market. This can lead to larger price gaps and sharper percentage swings, especially during early trading hours.

As always, diversification remains a key principle. Holding a broad basket of ADRs, such as through an index fund or ETF, can help smooth out the wild swings of individual names. But even then, it's worth remembering that the index itself may not fully reflect the risk in your portfolio.

Looking ahead, investors will likely watch whether this dispersion continues or narrows. If single-stock moves remain wide, it could signal that market participants are still digesting company-specific news rather than a clear directional trend in Asian equities. For now, the index's near-flat move is less a sign of calm and more a reflection of offsetting forces.

More from this story

Next article · Don't miss

Swiss inflation climbs to 1.5% as Lonza buys five US plants from Merck KGaA

Swiss consumer prices rose to 1.5% in October, driven by higher energy costs. Meanwhile, contract drugmaker Lonza is expanding its US footprint with a five-site acquisition from Merck KGaA, a deal that could boost its revenue visibility.

Read the story →
Swiss inflation climbs to 1.5% as Lonza buys five US plants from Merck KGaA